Position in IDYA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,888,310
-$1,480,024 QoQ
Shares Held
86,684
-31.4% QoQ
Ownership
0.099%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in IDYA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Rafferty Asset Management, LLC holds $408,627,656 across 136 Biotechnology names. IDYA ranks #55 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
54,572 | $24,368,580 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
29,589 | $22,861,644 | |
| 3 | INSM |
INSMED Inc
|
116,069 | $18,979,602 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
50,553 | $16,726,471 | |
| 5 | APLS |
Apellis Pharmaceuticals, Inc.
|
180,471 | $7,260,348 | |
| 6 | MRNA |
Moderna, Inc.
|
114,194 | $5,801,055 | |
| 7 | INCY |
Incyte Corp
|
60,565 | $5,700,377 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
10,452 | $5,471,308 |
All Filings in IDYA
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,888,310 | 86,684 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,368,334 | 126,362 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,534,665 | 93,152 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,308,143 | 109,807 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,988,335 | 121,388 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $3,038,433 | 118,227 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,992,281 | 126,019 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $4,602,780 | 131,096 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $8,832,649 | 201,291 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $6,879,606 | 193,356 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $3,482,470 | 129,076 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,937,899 | 125,017 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,752,401 | 127,633 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $2,802,958 | 154,263 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,672,815 | 112,119 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $609,504 | 44,167 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,219,027 | 108,939 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,522,506 | 106,705 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $802,297 | 31,475 | Shares | Sole | 2021-11-10 | |
| No filing history on record for this holder in this stock. | ||||||